| Product |
Injection Technology
|
|---|---|
| Description of Project |
Realizing the importance of reshoring our pharmaceutical supply chain, HHS ASPR undertook efforts beginning in 2019 and during Operation Warp Speed in 2020 to accelerate the building of a new U.S.-based, high-speed, population-scale manufacturing capacity for pre-filled syringes, investing a total of $181 million. These combined projects commercialized Blow-Fill-Seal (BFS) manufacturing in the United States and established capacities to manufacture a minimum of 45 million prefilled syringes per month. |
| Unique Impact |
This contract will allow for the manufacturing of prefilled syringes for distribution across the United States. |
| Base Award Amount |
$181,100,000.00
|
| Category |
Therapeutics Supplies and Raw Materials
|
Official websites use .gov
A .gov website belongs to an official government organization in the United
States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely
connected to the .gov website. Share sensitive information only on official, secure websites.
